The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low–Expressing Cancer In Vitro and In Vivo-Reference-Cited by-同舟云学术

The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low–Expressing Cancer In Vitro and In Vivo

Published:2021-04-27 Issue: Volume: Page:
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Dreyer Tobias F.^ORCID,Kuhn Sabine,Stange Christoph^ORCID,Heithorst Nadine,Schilling Daniela^ORCID,Jelsma Jil,Sievert Wolfgang,Seitz Stefanie,Stangl Stefan^ORCID,Hapfelmeier Alexander,Noske Aurelia,Wege Anja K.^ORCID,Weichert Wilko,Ruland Jürgen^ORCID,Schmitt Manfred,Dorn Julia^ORCID,Kiechle Marion^ORCID,Reuning Ute,Magdolen Viktor^ORCID,Multhoff Gabriele,Bronger Holger

Funder

Deutsche Forschungsgemeinschaft

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fractalkine in Health and Disease;International Journal of Molecular Sciences;2024-07-23

2. Induction of CX3CL1 expression by LPS and its impact on invasion and migration in oral squamous cell carcinoma;Frontiers in Cell and Developmental Biology;2024-06-10

3. CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis;International Journal of Molecular Sciences;2024-04-25

4. Spinal Cord Stimulation Increases Chemoefficacy and Prevents Paclitaxel-Induced Pain via CX3CL1;Neuromodulation: Technology at the Neural Interface;2023-07

5. The trichotomy of HER2 expression confers new insights into the understanding and managing for breast cancer stratified by HER2 status;International Journal of Cancer;2023-06-14